CREBBP and myeloproliferative disorder: One can thus imagine that MDS and AML in Crebbp+/- animals (and potentially secondary AML in MPN) results from the coordinated, aberrant action of several marrow components—not necessarily all bearing mutations—rather than from the isolated activity of a unique, phenotypically defined disease progenitor.